 Home > Medical News > Latest Medical News > Watson Pharmaceutical Liuwei Anshen Capsules and Bumetanide for Injection Received Drug Re-registration Approval

Watson Pharmaceutical Liuwei Anshen Capsules and Bumetanide for Injection Received Drug Re-registration Approval

 Last Update: 2021-08-08
 Source: Internet
 Author: User

Tags

meijer drug test

rcvs treatment

Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

On July 5, Watson Pharmaceuticals announced that it had recently received the "Drug Reregistration Approval Notice" for the company's two products, Liuwei Anshen Capsules and Bumetanide for Injection, approved and issued by the Chongqing Drug Administration

(1) Liuwei Anshen Capsules

(2) Bumetanide for injection

(1) Edema diseases include congestive heart failure, liver cirrhosis, kidney disease (nephritis, nephropathy and various causes of acute and chronic renal failure), especially when the effect of other diuretics is not good, use this class of drugs It may still work

(2) Hypertension

(3) Prevention of acute renal failure is used for various reasons that lead to insufficient renal blood perfusion, such as water loss, shock, poisoning, accidental anesthesia, and circulatory insufficiency.

(4) Hyperkalemia and hypercalcemia

(5) Dilutional hyponatremia, especially when the blood sodium concentration is lower than 120mmol/L

(6) Antidiuretic hormone hypersecretion syndrome (SIADH)

(7) Treatment of acute drug poisoning, such as barbiturate poisoning

(8) Some cases where furosemide is ineffective may still be effective

This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

Related Products

L-Ascorbate-2-Monophosphate Feed Grade

CAS No.: 109620-90-8

Feed Grade

Potassium Sorbate from reliable manufacturer

CAS No.: 590-00-1

Food Grade

Doxycycline Hydrochloride

CAS No.: 10592-13-9

Pharmaceutical Grade

Hot Tags

jobs united states(236)

united states jobs(223)

1 year treasury(277)

1 year subscription(296)

single use technology(195)

ups united states(221)

announcements today(81)

united states logo(227)

80 20 company(94)

healthy food name(42)

Hot Articles

The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.